TWI400042B - Food tablet - Google Patents
Food tablet Download PDFInfo
- Publication number
- TWI400042B TWI400042B TW096120822A TW96120822A TWI400042B TW I400042 B TWI400042 B TW I400042B TW 096120822 A TW096120822 A TW 096120822A TW 96120822 A TW96120822 A TW 96120822A TW I400042 B TWI400042 B TW I400042B
- Authority
- TW
- Taiwan
- Prior art keywords
- food
- combination
- lozenge
- tablet
- excipient
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims description 31
- 239000003826 tablet Substances 0.000 claims description 36
- 239000007937 lozenge Substances 0.000 claims description 21
- 239000004480 active ingredient Substances 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
- 238000013270 controlled release Methods 0.000 claims description 9
- 239000003085 diluting agent Substances 0.000 claims description 8
- 239000000049 pigment Substances 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000011230 binding agent Substances 0.000 claims description 5
- 239000000314 lubricant Substances 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- -1 hydroxypropyl group Chemical group 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 2
- 244000119461 Garcinia xanthochymus Species 0.000 claims description 2
- 235000000885 Garcinia xanthochymus Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims description 2
- 235000007164 Oryza sativa Nutrition 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 241000533293 Sesbania emerus Species 0.000 claims description 2
- 239000005084 Strontium aluminate Substances 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- KWVFUTDPKIKVQW-UHFFFAOYSA-N [Sr].[Na] Chemical compound [Sr].[Na] KWVFUTDPKIKVQW-UHFFFAOYSA-N 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- 230000037396 body weight Effects 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 2
- 235000013539 calcium stearate Nutrition 0.000 claims description 2
- 239000008116 calcium stearate Substances 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical group O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 claims description 2
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 claims description 2
- 239000008120 corn starch Substances 0.000 claims description 2
- 229960001681 croscarmellose sodium Drugs 0.000 claims description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 2
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 239000000576 food coloring agent Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 239000008104 plant cellulose Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 235000009566 rice Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- 235000020733 paullinia cupana extract Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- 230000003111 delayed effect Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- General Preparation And Processing Of Foods (AREA)
Description
本發明係有關一種食品錠劑,特別是一種用以將目標成分以不同速率釋放出來之食品錠劑。The present invention relates to a food lozenge, and more particularly to a food lozenge for releasing the target ingredients at different rates.
由於錠劑型式具有服用方便、易於保存等優點,因此,錠劑應用於口服藥劑已相當普遍。一般而言,一種錠劑通常僅具有單一目的之功效,因此,若需要達到多種功效時,使用者便需服用多種錠劑。此外,依不同需求,即效性之錠劑以及長效性之錠劑亦被開發出來並應用於醫藥領域中。Because of the advantages of convenient dosage and easy storage, the tablet dosage is quite common for oral administration. In general, a lozenge usually only has a single purpose effect, so if a variety of effects are required, the user will need to take a variety of lozenges. In addition, depending on the needs, immediate lozenges and long-acting lozenges have also been developed and used in the pharmaceutical field.
然而,上述錠劑的應用方式在食品領域並不多見。舉例而言,一種習知之控制體重方式是在用餐前服用提供飽足感之錠劑以減少食量,並在用餐後服用促進代謝之錠劑以增加熱量消耗。對消費者而言,使用上並不便利。However, the application of the above-mentioned tablets is not common in the food field. For example, one conventional method of controlling body weight is to take a tablet that provides satiety before meals to reduce the amount of food, and to take a tablet that promotes metabolism after meals to increase calorie expenditure. For consumers, it is not convenient to use.
綜上所述,如何以單一食品錠劑即達到所需之不同目的及功效便是目前極需努力的目標。In summary, how to achieve the different purposes and effects required with a single food lozenge is the goal that is currently in great demand.
針對上述問題,本發明目的之一是提供一種食品錠劑,其結合快速崩解以及延緩釋放之技術,使目標成分以不同速率釋放出來。In view of the above problems, it is an object of the present invention to provide a food lozenge which combines rapid disintegration and delayed release techniques to release target ingredients at different rates.
為了達到上述目的,本發明一實施例之食品錠劑是用以將目標成分以不同速率釋放出來,其包含一第一層錠劑以及一第二層錠劑。第一層錠劑包含一第一有效成分、一第一控制釋放劑以及一第一賦形劑;第二層錠劑包含一第二有效成分、一第二控制釋放劑以及一第二賦形劑,其中,當食品錠劑被一使用者食用後,第一層錠劑於一預定時間內崩解,以釋放出第一有效成分,而第二層錠劑持續釋放第二有效成分之時間大於上述之預定時間。In order to achieve the above object, a food tablet according to an embodiment of the present invention is used to release a target ingredient at a different rate, and comprises a first layer tablet and a second layer tablet. The first tablet comprises a first active ingredient, a first controlled release agent and a first excipient; the second layer of the tablet comprises a second active ingredient, a second controlled release agent and a second shaped form The agent, wherein, when the food tablet is consumed by a user, the first layer of the tablet disintegrates within a predetermined time to release the first active ingredient, and the second layer of tablet continues to release the second active ingredient More than the predetermined time mentioned above.
以下藉由具體實施例配合所附的圖式詳加說明,當更容易瞭解本發明之目的、技術內容、特點及其所達成之功效。The purpose, technical contents, features, and effects achieved by the present invention will become more apparent from the detailed description of the appended claims.
本發明之一較佳實施例之食品錠劑是用以將目標成分以不同速率釋放出來。本發明之食品錠劑包含一第一層錠劑以及一第二層錠劑,其中第一層錠劑包含一第一有效成分、一第一控制釋放劑以及一第一賦形劑,第二層錠劑包含一第二有效成分、一第二控制釋放劑以及一第二賦形劑。利用快速崩解的配方設計,第一層錠劑被使用者食用後,在一預定時間內崩解而釋放出該第一成分。此外,亦利用延緩釋放的配方設計,使第二層錠劑可持續釋放第二成分,且持續釋放的時間大於第一層錠劑崩解的預定時間。A food lozenge according to a preferred embodiment of the invention is used to release the target ingredients at different rates. The food tablet of the present invention comprises a first layer tablet and a second layer tablet, wherein the first layer tablet comprises a first active ingredient, a first controlled release agent and a first excipient, and second The tablet comprises a second active ingredient, a second controlled release agent, and a second excipient. With the rapid disintegration formulation, the first layer of tablet is disintegrated within a predetermined time to release the first component after being consumed by the user. In addition, the delayed release formulation is also utilized to allow the second layer of tablet to sustain release of the second component for a sustained release time greater than the predetermined time for disintegration of the first layer of tablet.
於一實施例中,本發明之食品錠劑被食用後,第一層錠劑因具有快速崩解配方之效果以釋放出第一有效成分。舉例而言,第一控制釋放劑包含微結晶狀α-纖維素、交聯羧甲基纖維素鈉以及羧甲基澱粉鈉,較佳者,結晶狀α-纖維素、交聯羧甲基纖維素鈉以及羧甲基澱粉鈉佔第一層錠劑之重量百分比分別為10~30%、2~4%以及2~4%。於一實施例中,第一控制釋放劑更可包含海藻酸。In one embodiment, after the food tablet of the present invention is consumed, the first layer of the tablet has the effect of a fast disintegrating formulation to release the first active ingredient. For example, the first controlled release agent comprises microcrystalline α-cellulose, croscarmellose sodium, and sodium carboxymethyl starch, preferably, crystalline α-cellulose, crosslinked carboxymethyl fiber The sodium and sodium carboxymethyl starch accounted for 10 to 30%, 2 to 4%, and 2 to 4%, respectively, of the first layer of the tablet. In an embodiment, the first controlled release agent may further comprise alginic acid.
接續上述說明,第二層錠劑則利用延緩釋放的技術,延緩釋放的效果可利用將第二有效成分包覆於微粒中來達成;或是利用添加溼潤劑的方式,使第二層錠劑於水溶液中形成一水合層,藉由水合層的阻隔以延長第二有效成分釋放至水溶液的時間。舉例而言,第二控制釋放劑可為水溶膠體。於一實施例中,水溶膠體可為羥丙基甲基纖維素,例如羥丙基含量為7~12%,甲基含量為19~24%,黏度為4000~15000 cP之羥丙基甲基纖維素,較佳者,羥丙基甲基纖維素佔第二層錠劑之重量百分比為10~30%。Following the above description, the second layer of the tablet uses a delayed release technique, and the effect of delaying the release can be achieved by coating the second active ingredient in the particles; or by adding a wetting agent to make the second layer of the tablet. A monohydrate layer is formed in the aqueous solution by the barrier of the hydration layer to extend the time during which the second active ingredient is released to the aqueous solution. For example, the second controlled release agent can be a hydrosol. In one embodiment, the hydrosol may be hydroxypropyl methylcellulose, such as hydroxypropylmethyl having a hydroxypropyl group content of 7 to 12%, a methyl group content of 19 to 24%, and a viscosity of 4000 to 15000 cP. Cellulose, preferably, hydroxypropyl methylcellulose comprises from 10% to 30% by weight of the second layer of tablet.
第一賦形劑主要包含一疏水性稀釋劑,例如疏水性稀釋劑可為玉米澱粉、預膠化澱粉、磷酸氫鈣、磷酸二鈣或以上之組合。第二賦形劑主要包含親水性稀釋劑,例如親水性稀釋劑可為異麥芽酮糖醇、甘露醇、木糖醇、麥芽糖、乳糖、麥芽糊精、蔗糖、葡萄糖或以上之組合。The first excipient primarily comprises a hydrophobic diluent, for example the hydrophobic diluent can be corn starch, pregelatinized starch, dibasic calcium phosphate, dicalcium phosphate or a combination thereof. The second excipient primarily comprises a hydrophilic diluent, for example the hydrophilic diluent can be isomalt, mannitol, xylitol, maltose, lactose, maltodextrin, sucrose, glucose or a combination thereof.
此外,第一賦形劑以及第二賦形劑更可包含潤滑劑、黏合劑、流動控制劑、色素、乳化劑或以上之組合。舉例而言,潤滑劑可為硬脂酸鎂、硬脂酸鈣、聚乙二醇或以上之組合;黏合劑可為聚乙烯吡咯烷酮、澱粉、糊精、甲基纖維素或以上之組合;流動控制劑可為二氧化矽、滑石粉、矽鋁酸鈉或以上之組合;色素則可為天然色素或人工食用色素。Further, the first excipient and the second excipient may further comprise a lubricant, a binder, a flow control agent, a pigment, an emulsifier, or a combination thereof. For example, the lubricant may be magnesium stearate, calcium stearate, polyethylene glycol or a combination thereof; the binder may be polyvinylpyrrolidone, starch, dextrin, methylcellulose or a combination thereof; The controlling agent may be ceria, talc, sodium strontium aluminate or a combination thereof; the pigment may be a natural pigment or an artificial food coloring.
本發明較佳實施例之食品錠劑,其中之第一有效成分可為具有吸收使用者消化道內油脂及/或提供使用者飽足感功效的成分,例如甲殼素、植物纖維素或以上之組合,而第二有效成分則可為具有提供促進使用者之油脂分解及代謝速率功效的成分,例如瓜拿納萃取,或是具有抑制脂質或醣類代謝途徑功效的成分,例如藤黃果、大豆胜肽、武靴葉、青咖啡豆以及紫米萃取,亦或是上述兩種功效的組合。如此一來,使用者僅需於用餐前服用本發明之食品錠劑,即可產生飽足感並吸收用餐後攝入的油脂,且長時間具有促進代謝或抑制脂質或醣類代謝的效果。需注意者,上述實施例是以第一有效成分以及第二有效成分具有不同功效來作說明,然而,本發明之食品錠劑亦不排除應用於具有相同功效之第一有效成分以及第二有效成分,或是多種有效成分混合應用。The food tablet of the preferred embodiment of the present invention, wherein the first active ingredient may be an ingredient having the function of absorbing oil in the digestive tract of the user and/or providing a feeling of satiety of the user, such as chitin, plant cellulose or the like. The combination, and the second active ingredient may be a component having an effect of promoting decomposition and metabolic rate of the oil of the user, such as Guarana extraction, or an ingredient having an effect of inhibiting a lipid or carbohydrate metabolic pathway, such as Garcinia Cambogia, Soy peptides, stalks, green coffee beans, and purple rice extracts are also combinations of the above two effects. In this way, the user only needs to take the food tablet of the present invention before eating, thereby producing a feeling of satiety and absorbing the fat which is ingested after eating, and has an effect of promoting metabolism or inhibiting metabolism of lipids or sugars for a long period of time. It should be noted that the above embodiment is described by having different effects of the first active ingredient and the second active ingredient, however, the food tablet of the present invention is not excluded from being applied to the first active ingredient having the same efficacy and the second effective Ingredients, or a mixture of active ingredients.
以下揭露二個實例配方,經打錠製程以製成本發明之食品錠劑。Two example formulations are disclosed below which are subjected to a tableting process to form a food lozenge of the present invention.
實例1:
實例2:
綜合上述,依據本發明之食品錠劑結合快速崩解的即效性以及延緩釋放的長效性於單一錠劑,其可於食品領域產生多種應用方式,例如作為控制體重之代餐等,如此可增進使用者使用上的方便性。In summary, the food tablet according to the present invention combines the instant disintegration of rapid disintegration with the long-acting effect of delayed release in a single tablet, which can be used in various applications in the food field, for example, as a meal replacement meal, etc. It can enhance the convenience of users.
以上所述之實施例僅是為說明本發明之技術思想及特點,其目的在使熟習此項技藝之人士能夠瞭解本發明之內容並據以實施,當不能以之限定本發明之專利範圍,即大凡依本發明所揭示之精神所作之均等變化或修飾,仍應涵蓋在本發明之專利範圍內。The embodiments described above are only intended to illustrate the technical idea and the features of the present invention, and the purpose of the present invention is to enable those skilled in the art to understand the contents of the present invention and to implement the present invention. That is, the equivalent variations or modifications made by the spirit of the present invention should still be included in the scope of the present invention.
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW096120822A TWI400042B (en) | 2007-06-08 | 2007-06-08 | Food tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW096120822A TWI400042B (en) | 2007-06-08 | 2007-06-08 | Food tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200847938A TW200847938A (en) | 2008-12-16 |
| TWI400042B true TWI400042B (en) | 2013-07-01 |
Family
ID=44823680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW096120822A TWI400042B (en) | 2007-06-08 | 2007-06-08 | Food tablet |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI400042B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6254886B1 (en) * | 1997-12-19 | 2001-07-03 | Merck Patent Gmbh | Multilayer tablet |
| TWI222885B (en) * | 1999-12-20 | 2004-11-01 | Schering Corp | Extended release oral dosage composition |
| TWI265927B (en) * | 2002-01-23 | 2006-11-11 | Schering Corp | Novel compounds as NS3-serine protease inhibitors of hepatitis C virus |
-
2007
- 2007-06-08 TW TW096120822A patent/TWI400042B/en active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6254886B1 (en) * | 1997-12-19 | 2001-07-03 | Merck Patent Gmbh | Multilayer tablet |
| TWI222885B (en) * | 1999-12-20 | 2004-11-01 | Schering Corp | Extended release oral dosage composition |
| TWI265927B (en) * | 2002-01-23 | 2006-11-11 | Schering Corp | Novel compounds as NS3-serine protease inhibitors of hepatitis C virus |
Non-Patent Citations (2)
| Title |
|---|
| 行政院衛生署食品資訊網,健康食品查驗登記現況,網址;http://food.fda.gov.tw/foodnew/info/InfoHealthFood.aspx?SN=29; * |
| 金車甲殼素複方膠囊,網址;http://www.gco.com.tw/product/goods_detail.php?bid=&goods_id=1452 鐘喜男、許立人,藥劑學入門,昭仁出版社,中華民國六十三年八月初版 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200847938A (en) | 2008-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6358526B1 (en) | Method of making tablets and tablet compositions produced therefrom | |
| CN102406679B (en) | Traditional Chinese medicine American ginseng buccal tablet | |
| CN101868228A (en) | Orally disintegrating tablets | |
| CN101309688A (en) | Compositions and methods for sustained release of beta-alanine | |
| JP7475393B2 (en) | Tablet Composition | |
| US20120015021A1 (en) | Anti-appetite adhesive compositions | |
| US8968768B2 (en) | Phytosterol nutritional supplements | |
| JP2013533881A (en) | Pharmaceutical composition containing vanoxerin | |
| CN102451162A (en) | Olanzapine medicine absorbed through oral mucosa | |
| TWI400042B (en) | Food tablet | |
| CN102727456B (en) | Drug port cavity disintegrating tablet and preparation method thereof | |
| US20080279931A1 (en) | Composition for treatment of pain | |
| JP7382409B2 (en) | Method for the preparation of easy-to-take tablets containing dried ginkgo leaf extract | |
| US10610556B2 (en) | Compositions for regulation and control of appetite | |
| CN100386071C (en) | A medicine for treating cough and asthma and chronic bronchitis | |
| JP2010270111A (en) | Arginine-containing tablet | |
| KR100857061B1 (en) | Tablet containing Bachynium myrtilus extract and its preparation method | |
| CA2639895C (en) | Energizing compositions comprising goji, red clover and polygonum multiflorum, and uses thereof | |
| CN107625875A (en) | A kind of preparation method and purposes of Allium wallichii extract | |
| JP6004702B2 (en) | Method for producing solid preparation with reduced unpleasant taste | |
| CN101590127B (en) | Compound medicine containing total flavone of hawthorn (leaf) and folic acid compound | |
| CN102048677A (en) | Valganciclovir Hydrochloride solid preparation and preparation method thereof | |
| JP2007302688A (en) | Quick-acting formulation | |
| US20080248136A1 (en) | Acute and chronic heartburn composition and method | |
| JP2026002788A (en) | Pharmaceutical Composition |